Symbols / MIR Stock $19.71 +1.18% Mirion Technologies, Inc.

Industrials • Specialty Industrial Machinery • United States • NYQ
MIR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Industrials
Industry Specialty Industrial Machinery
CEO Mr. Thomas D. Logan
Exch · Country NYQ · United States
Market Cap 4.95B
Enterprise Value 5.69B
Income 28.80M
Sales 925.40M
FCF (ttm) 126.47M
Book/sh 7.63
Cash/sh 1.71
Employees 3,281
Insider 10d —
IPO Aug 20, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 179.18
Forward P/E 29.46
PEG —
P/S 5.35
P/B 2.58
P/C —
EV/EBITDA 27.77
EV/Sales 6.15
Quick Ratio 2.24
Current Ratio 2.83
Debt/Eq 64.36
LT Debt/Eq —
EPS (ttm) 0.11
EPS next Y 0.67
EPS Growth 2.40%
Revenue Growth 9.10%
EPS Gr Q/Q 15.30%
Rev Gr Q/Q —
Earnings (next) 2026-04-28
Earnings (prior) 2026-02-10
ROA 1.34%
ROE 1.71%
ROIC —
Gross Margin 47.43%
Oper. Margin 14.20%
Profit Margin 3.11%
Shs Outstand 244.39M
Shs Float 226.73M
Insider Own 3.50%
Instit Own 109.75%
Short Float 13.08%
Short Ratio 6.36
Short Interest 22.21M
52W High 30.28
vs 52W High -34.90%
52W Low 14.62
vs 52W Low 34.82%
Beta 1.09
Impl. Vol. 0.78%
Rel Volume 0.82
Avg Volume 3.61M
Volume 2.95M
Target (mean) $28.10
Tgt Median $28.50
Tgt Low $26.00
Tgt High $29.00
# Analysts 10
Recom Strong_buy
Prev Close $19.48
Price $19.71
Change 1.18%
About

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$28.10
Mean price target
2. Current target
$19.71
Latest analyst target
3. DCF / Fair value
$9.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$19.71
Low
$26.00
High
$29.00
Mean
$28.10

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 main Baird Outperform → Outperform $26
2026-03-26 main JP Morgan Overweight → Overweight $27
2026-03-11 main Morgan Stanley Equal-Weight → Equal-Weight $27
2026-03-09 main JP Morgan Overweight → Overweight $30
2026-02-12 main Citigroup Buy → Buy $29
2026-02-12 main Goldman Sachs Buy → Buy $29
2026-01-23 init Morgan Stanley — → Equal-Weight $29
2025-12-08 main Citigroup Buy → Buy $33
2025-11-25 init Evercore ISI Group — → Outperform $29
2025-10-31 main Citigroup Buy → Buy $35
2025-10-30 main JP Morgan Overweight → Overweight $34
2025-10-09 main Citigroup Buy → Buy $28
2025-09-29 main Northland Capital Markets Outperform → Outperform $29
2025-09-29 main Baird Outperform → Outperform $26
2025-09-26 init JP Morgan — → Overweight $28
2025-09-16 main Goldman Sachs Buy → Buy $25
2025-08-25 init Northland Capital Markets — → Outperform $26
2025-07-23 reit B. Riley Securities Buy → Buy $22
2025-07-14 main Citigroup Buy → Buy $24
2025-07-09 main Baird Outperform → Outperform $22
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 KINGSLEY LAWRENCE D Director — 1,104 $17.32 $19,121
2026-03-02 SCHOPFER BRIAN Chief Financial Officer — 64,906 $0.00 $0
2026-03-02 LOGAN THOMAS D. Chief Executive Officer — 318,632 $0.00 $0
2026-03-02 LOGAN THOMAS D. Chief Executive Officer — 3,093,812 $0.00 $0
2026-03-02 ELOY LOIC Officer — 15,577 $0.00 $0
2026-02-27 MOORE CHRISTOPHER A. Officer — 5,552 $0.00 $0
2026-02-27 LEE EMMANUELLE Officer — 11,568 $0.00 $0
2026-02-27 ULRICH ALISON Officer — 5,552 $0.00 $0
2025-12-31 KINGSLEY LAWRENCE D Director — 806 $23.70 $19,102
2025-12-11 KUO JOHN W Director — 4,860 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
925.40
+7.50%
860.80
+7.48%
800.90
+11.58%
717.80
Operating Revenue
925.40
+7.50%
860.80
+7.48%
800.90
+11.58%
717.80
Cost Of Revenue
486.80
+5.57%
461.10
+3.73%
444.50
+9.03%
407.70
Reconciled Cost Of Revenue
486.80
+5.57%
461.10
+3.73%
444.50
+9.03%
407.70
Gross Profit
438.60
+9.73%
399.70
+12.15%
356.40
+14.93%
310.10
Operating Expense
387.10
+2.92%
376.10
+1.16%
371.80
-5.30%
392.60
Research And Development
38.90
+11.14%
35.00
+10.41%
31.70
+4.62%
30.30
Selling General And Administration
348.20
+2.08%
341.10
+0.29%
340.10
-6.13%
362.30
Total Expenses
873.90
+4.38%
837.20
+2.56%
816.30
+2.00%
800.30
Operating Income
51.50
+118.22%
23.60
+253.25%
-15.40
+81.33%
-82.50
Total Operating Income As Reported
51.50
+107.66%
24.80
+213.24%
-21.90
+92.65%
-297.80
EBITDA
212.90
+22.08%
174.40
+46.06%
119.40
+233.26%
-89.60
Normalized EBITDA
201.30
+11.40%
180.70
+18.10%
153.00
+64.52%
93.00
Reconciled Depreciation
138.00
-8.24%
150.40
-7.62%
162.80
-6.70%
174.50
EBIT
74.90
+212.08%
24.00
+155.30%
-43.40
+83.57%
-264.10
Total Unusual Items
11.60
+284.13%
-6.30
+81.25%
-33.60
+81.60%
-182.60
Total Unusual Items Excluding Goodwill
11.60
+284.13%
-6.30
+81.25%
-33.60
+81.60%
-182.60
Special Income Charges
-5.80
-583.33%
1.20
+113.19%
-9.10
+95.77%
-215.30
Other Special Charges
5.80
—
2.60
—
Impairment Of Capital Assets
—
0.00
0.00
-100.00%
211.80
Write Off
—
0.00
0.00
-100.00%
3.50
Net Income
28.80
+179.78%
-36.10
+62.75%
-96.90
+65.01%
-276.90
Pretax Income
32.70
+196.46%
-33.90
+67.81%
-105.30
+65.66%
-306.60
Net Non Operating Interest Income Expense
-30.10
+41.33%
-51.30
+10.16%
-57.10
-36.28%
-41.90
Interest Expense Non Operating
42.20
-27.12%
57.90
-6.46%
61.90
+45.65%
42.50
Net Interest Income
-30.10
+41.33%
-51.30
+10.16%
-57.10
-36.28%
-41.90
Interest Expense
42.20
-27.12%
57.90
-6.46%
61.90
+45.65%
42.50
Interest Income Non Operating
12.10
+83.33%
6.60
+37.50%
4.80
+700.00%
0.60
Interest Income
12.10
+83.33%
6.60
+37.50%
4.80
+700.00%
0.60
Other Income Expense
11.30
+282.26%
-6.20
+81.10%
-32.80
+82.00%
-182.20
Other Non Operating Income Expenses
-0.30
-400.00%
0.10
-87.50%
0.80
+100.00%
0.40
Gain On Sale Of Security
17.40
+332.00%
-7.50
+69.39%
-24.50
-174.92%
32.70
Gain On Sale Of Business
0.00
-100.00%
1.20
+118.46%
-6.50
0.00
Tax Provision
2.90
+7.41%
2.70
+140.91%
-6.60
+63.74%
-18.20
Tax Rate For Calcs
0.00
-57.62%
0.00
+233.33%
0.00
+6.78%
0.00
Tax Effect Of Unusual Items
1.03
+178.03%
-1.32
+37.50%
-2.12
+80.35%
-10.77
Net Income Including Noncontrolling Interests
29.80
+181.42%
-36.60
+62.92%
-98.70
+65.78%
-288.40
Net Income From Continuing Operation Net Minority Interest
28.80
+179.78%
-36.10
+62.75%
-96.90
+65.01%
-276.90
Net Income From Continuing And Discontinued Operation
28.80
+179.78%
-36.10
+62.75%
-96.90
+65.01%
-276.90
Net Income Continuous Operations
29.80
+181.42%
-36.60
+62.92%
-98.70
+65.78%
-288.40
Minority Interests
-1.00
-300.00%
0.50
-72.22%
1.80
-84.35%
11.50
Normalized Income
18.23
+158.58%
-31.12
+52.42%
-65.42
+37.74%
-105.07
Net Income Common Stockholders
28.80
+179.78%
-36.10
+62.75%
-96.90
+65.01%
-276.90
Diluted EPS
—
-0.18
+63.27%
-0.49
+67.97%
-1.53
Basic EPS
—
-0.18
+63.27%
-0.49
+67.97%
-1.53
Basic Average Shares
—
204.99
+4.39%
196.37
+8.40%
181.15
Diluted Average Shares
—
204.99
+4.39%
196.37
+8.40%
181.15
Diluted NI Availto Com Stockholders
28.80
+179.78%
-36.10
+62.75%
-96.90
+65.01%
-276.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
3,588.10
+36.12%
2,636.00
-3.03%
2,718.50
Current Assets
893.70
+50.28%
594.70
+10.42%
538.60
Cash Cash Equivalents And Short Term Investments
419.20
+131.47%
181.10
+35.05%
134.10
Cash And Cash Equivalents
412.30
+135.33%
175.20
+36.02%
128.80
Other Short Term Investments
6.90
+16.95%
5.90
+11.32%
5.30
Receivables
290.00
+14.49%
253.30
+9.94%
230.40
Accounts Receivable
181.60
+2.19%
177.70
+3.13%
172.30
Other Receivables
93.80
+40.00%
67.00
+37.58%
48.70
Taxes Receivable
14.60
+69.77%
8.60
-8.51%
9.40
Inventory
152.60
+14.56%
133.20
-7.56%
144.10
Raw Materials
82.90
+30.35%
63.60
-5.36%
67.20
Work In Process
34.70
+9.46%
31.70
-10.20%
35.30
Finished Goods
35.00
-7.65%
37.90
-8.89%
41.60
Prepaid Assets
12.60
-4.55%
13.20
+9.09%
12.10
Current Deferred Assets
—
—
—
Restricted Cash
2.80
+833.33%
0.30
-50.00%
0.60
Assets Held For Sale Current
—
—
0.00
Other Current Assets
16.50
+21.32%
13.60
-21.39%
17.30
Total Non Current Assets
2,694.40
+31.99%
2,041.30
-6.36%
2,179.90
Net PPE
187.00
+5.89%
176.60
+5.56%
167.30
Gross PPE
283.40
+9.93%
257.80
+15.14%
223.90
Accumulated Depreciation
-96.40
-18.72%
-81.20
-43.46%
-56.60
Properties
58.00
+11.11%
52.20
+5.67%
49.40
Machinery Furniture Equipment
92.50
+11.85%
82.70
+34.69%
61.40
Construction In Progress
59.50
+40.66%
42.30
+7.63%
39.30
Other Properties
73.40
-8.93%
80.60
+9.21%
73.80
Goodwill And Other Intangible Assets
2,478.70
+34.87%
1,837.80
-7.48%
1,986.40
Goodwill
1,872.40
+31.29%
1,426.20
-1.48%
1,447.60
Other Intangible Assets
606.30
+47.30%
411.60
-23.61%
538.80
Non Current Accounts Receivable
—
—
—
Other Non Current Assets
28.70
+6.69%
26.90
+2.67%
26.20
Total Liabilities Net Minority Interest
1,671.20
+55.19%
1,076.90
-7.84%
1,168.50
Current Liabilities
316.10
+19.96%
263.50
-0.83%
265.70
Payables And Accrued Expenses
101.10
+5.09%
96.20
+3.44%
93.00
Payables
76.80
+3.09%
74.50
-0.27%
74.70
Accounts Payable
57.40
+1.59%
56.50
-3.75%
58.70
Current Accrued Expenses
24.30
+11.98%
21.70
+18.58%
18.30
Pensionand Other Post Retirement Benefit Plans Current
52.10
+14.76%
45.40
+7.84%
42.10
Total Tax Payable
19.40
+7.78%
18.00
+12.50%
16.00
Income Tax Payable
6.60
-7.04%
7.10
+69.05%
4.20
Current Debt And Capital Lease Obligation
9.30
+22.37%
7.60
-5.00%
8.00
Current Debt
1.60
+33.33%
1.20
+0.00%
1.20
Other Current Borrowings
1.60
+33.33%
1.20
+0.00%
1.20
Current Capital Lease Obligation
7.70
+20.31%
6.40
-5.88%
6.80
Current Deferred Liabilities
132.90
+19.84%
110.90
-0.89%
111.90
Current Deferred Revenue
131.80
+18.85%
110.90
-0.89%
111.90
Other Current Liabilities
20.70
+508.82%
3.40
-68.22%
10.70
Total Non Current Liabilities Net Minority Interest
1,355.10
+66.60%
813.40
-9.90%
902.80
Long Term Debt And Capital Lease Obligation
1,224.40
+71.89%
712.30
-0.07%
712.80
Long Term Debt
1,197.60
+74.78%
685.20
+0.07%
684.70
Long Term Capital Lease Obligation
26.80
-1.11%
27.10
-3.56%
28.10
Non Current Deferred Liabilities
70.00
+14.57%
61.10
-27.26%
84.00
Non Current Deferred Taxes Liabilities
70.00
+14.57%
61.10
-27.26%
84.00
Other Non Current Liabilities
60.70
+51.75%
40.00
-21.10%
50.70
Stockholders Equity
1,866.40
+23.96%
1,505.60
+1.42%
1,484.50
Common Stock Equity
1,866.40
+23.96%
1,505.60
+1.42%
1,484.50
Capital Stock
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
Share Issued
248.16
+9.84%
225.92
+3.55%
218.18
Ordinary Shares Number
244.66
+8.44%
225.63
+3.49%
218.03
Treasury Shares Number
3.49
+1112.66%
0.29
+93.20%
0.15
Additional Paid In Capital
2,490.10
+16.18%
2,143.30
+4.22%
2,056.50
Retained Earnings
-512.70
+5.32%
-541.50
-7.14%
-505.40
Gains Losses Not Affecting Retained Earnings
-52.60
+43.44%
-93.00
-42.42%
-65.30
Treasury Stock
58.40
+1725.00%
3.20
+146.15%
1.30
Minority Interest
50.50
-5.61%
53.50
-18.32%
65.50
Other Equity Adjustments
-52.60
+43.44%
-93.00
-42.42%
-65.30
Total Equity Gross Minority Interest
1,916.90
+22.95%
1,559.10
+0.59%
1,550.00
Total Capitalization
3,064.00
+39.86%
2,190.80
+1.00%
2,169.20
Working Capital
577.60
+74.40%
331.20
+21.36%
272.90
Invested Capital
3,065.60
+39.85%
2,192.00
+1.00%
2,170.40
Total Debt
1,233.70
+71.37%
719.90
-0.12%
720.80
Net Debt
786.90
+53.93%
511.20
-8.24%
557.10
Capital Lease Obligations
34.50
+2.99%
33.50
-4.01%
34.90
Net Tangible Assets
-612.30
-84.32%
-332.20
+33.81%
-501.90
Tangible Book Value
-612.30
-84.32%
-332.20
+33.81%
-501.90
Derivative Product Liabilities
—
0.00
-100.00%
55.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
143.30
+44.60%
99.10
+4.10%
95.20
+141.62%
39.40
Cash Flow From Continuing Operating Activities
143.30
+44.60%
99.10
+4.10%
95.20
+141.62%
39.40
Net Income From Continuing Operations
29.80
+181.42%
-36.60
+62.92%
-98.70
+65.78%
-288.40
Depreciation Amortization Depletion
138.00
-8.24%
150.40
-7.62%
162.80
-6.70%
174.50
Depreciation
35.60
+11.60%
31.90
+1.27%
31.50
+9.76%
28.70
Amortization Cash Flow
102.40
-13.59%
118.50
-9.75%
131.30
-9.95%
145.80
Depreciation And Amortization
138.00
-8.24%
150.40
-7.62%
162.80
-6.70%
174.50
Amortization Of Intangibles
102.40
-13.59%
118.50
-9.75%
131.30
-9.95%
145.80
Other Non Cash Items
5.20
+6.12%
4.90
+96.00%
2.50
-81.34%
13.40
Stock Based Compensation
15.20
-2.56%
15.60
-28.77%
21.90
-31.13%
31.80
Provisionand Write Offof Assets
2.50
-26.47%
3.40
+88.89%
1.80
+500.00%
0.30
Asset Impairment Charge
1.60
-69.23%
5.20
+126.09%
2.30
-98.92%
212.70
Deferred Tax
-22.30
+6.30%
-23.80
+22.98%
-30.90
+16.94%
-37.20
Deferred Income Tax
-22.30
+6.30%
-23.80
+22.98%
-30.90
+16.94%
-37.20
Operating Gains Losses
-11.00
-261.76%
6.80
-80.12%
34.20
+216.72%
-29.30
Gain Loss On Investment Securities
—
5.30
-78.63%
24.80
+165.96%
-37.60
Net Foreign Currency Exchange Gain Loss
-17.40
-890.91%
2.20
+833.33%
-0.30
-106.12%
4.90
Gain Loss On Sale Of PPE
0.60
+20.00%
0.50
-16.67%
0.60
-82.35%
3.40
Change In Working Capital
-15.70
+41.42%
-26.80
-3728.57%
-0.70
+98.18%
-38.40
Change In Receivables
6.90
+119.22%
-35.90
-1058.06%
-3.10
+83.94%
-19.30
Changes In Account Receivables
14.60
+221.67%
-12.00
-140.00%
-5.00
+66.22%
-14.80
Change In Inventory
3.30
+153.85%
1.30
+360.00%
-0.50
+98.56%
-34.80
Change In Prepaid Assets
-9.40
-261.54%
-2.60
+81.43%
-14.00
-483.33%
-2.40
Change In Payables And Accrued Expense
-11.10
-213.27%
9.80
+234.25%
-7.30
-173.00%
10.00
Change In Accrued Expense
-0.30
-102.65%
11.30
+334.62%
2.60
-52.73%
5.50
Change In Payable
-10.80
-620.00%
-1.50
+84.85%
-9.90
-320.00%
4.50
Change In Account Payable
-10.80
-620.00%
-1.50
+84.85%
-9.90
-320.00%
4.50
Change In Other Working Capital
-1.00
-25.00%
-0.80
-103.25%
24.60
+303.28%
6.10
Change In Other Current Assets
-1.30
-244.44%
0.90
+200.00%
0.30
-94.44%
5.40
Change In Other Current Liabilities
-3.10
-720.00%
0.50
+171.43%
-0.70
+79.41%
-3.40
Investing Cash Flow
-694.60
-1489.47%
-43.70
+32.46%
-64.70
-63.80%
-39.50
Cash Flow From Continuing Investing Activities
-694.60
-1489.47%
-43.70
+32.46%
-64.70
-63.80%
-39.50
Net PPE Purchase And Sale
-35.40
+27.46%
-48.80
-31.54%
-37.10
-11.08%
-33.40
Purchase Of PPE
-36.40
+25.41%
-48.80
-31.54%
-37.10
-8.48%
-34.20
Sale Of PPE
1.00
0.00
0.00
-100.00%
0.80
Capital Expenditure
-36.40
+25.41%
-48.80
-31.54%
-37.10
-8.48%
-34.20
Net Investment Purchase And Sale
2.70
-25.00%
3.60
-5.26%
3.80
+660.00%
0.50
Sale Of Investment
2.70
-25.00%
3.60
-5.26%
3.80
+660.00%
0.50
Net Business Purchase And Sale
-661.90
-44226.67%
1.50
+104.93%
-30.40
-360.61%
-6.60
Purchase Of Business
-661.90
-66090.00%
-1.00
+96.82%
-31.40
-375.76%
-6.60
Gain Loss On Sale Of Business
0.00
+100.00%
-1.20
-118.46%
6.50
0.00
Net Other Investing Changes
—
—
-1.00
—
Financing Cash Flow
775.90
+23612.12%
-3.30
-114.60%
22.60
+422.86%
-7.00
Cash Flow From Continuing Financing Activities
775.90
+23612.12%
-3.30
-114.60%
22.60
+422.86%
-7.00
Net Issuance Payments Of Debt
510.40
0.00
+100.00%
-127.30
-1828.79%
-6.60
Issuance Of Debt
755.00
0.00
0.00
0.00
Repayment Of Debt
-244.60
0.00
+100.00%
-127.30
-1828.79%
-6.60
Long Term Debt Issuance
755.00
0.00
0.00
0.00
Long Term Debt Payments
-244.60
0.00
+100.00%
-127.30
-1828.79%
-6.60
Net Long Term Debt Issuance
510.40
0.00
+100.00%
-127.30
-1828.79%
-6.60
Short Term Debt Issuance
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
369.00
+18550.00%
-2.00
-101.34%
149.00
0.00
Common Stock Payments
-56.00
-2700.00%
-2.00
-100.00%
-1.00
0.00
Repurchase Of Capital Stock
-56.00
-2700.00%
-2.00
-100.00%
-1.00
0.00
Net Other Financing Charges
-103.50
-7861.54%
-1.30
-244.44%
0.90
+325.00%
-0.40
Changes In Cash
224.60
+331.09%
52.10
-1.88%
53.10
+847.89%
-7.10
Effect Of Exchange Rate Changes
15.00
+314.29%
-7.00
-391.67%
2.40
+175.00%
-3.20
Beginning Cash Position
175.60
+34.56%
130.50
+74.00%
75.00
-12.08%
85.30
End Cash Position
415.20
+136.45%
175.60
+34.56%
130.50
+74.00%
75.00
Free Cash Flow
106.90
+112.52%
50.30
-13.43%
58.10
+1017.31%
5.20
Common Stock Issuance
425.00
0.00
-100.00%
150.00
0.00
Issuance Of Capital Stock
425.00
0.00
-100.00%
150.00
0.00
Sale Of Business
0.00
-100.00%
2.50
+150.00%
1.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category